During the past decade, Allergy, Asthma & Immunology Clinic, P.A conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy, Asthma & Immunology Clinic, P.A" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Bio Products Laboratory" with 2 trials sponsored, "ADMA Biologics, Inc." with 1 trials sponsored, "FFF Enterprises" with 1 trials sponsored and "Green Cross Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy, Asthma & Immunology Clinic, P.A" #1 collaborator was "Atlantic Research Group" with 1 trials as a collaborator, "OMRIX Biopharmaceuticals" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Allergy, Asthma & Immunology Clinic, P.A" are "Immunologic Deficiency Syndromes" (2 trials), "Primary Immunodeficiency" (2 trials), "Primary Immunodeficiency Diseases (PID)" (2 trials), "Wiskott-Aldrich Syndrome" (2 trials) and "Common Variable Hypogammaglobulinemia" (1 trials). Many other conditions were trialed in "Allergy, Asthma & Immunology Clinic, P.A" in a lesser frequency.

Most popular intervention types in "Allergy, Asthma & Immunology Clinic, P.A" are "Biological" (7 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "GC5107" (1 trials), "Gammaplex" (1 trials), "Gammaplex (Intravenous immunoglobulin)" (1 trials), "Gamunex-C" (1 trials) and "IVIG-PEG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy, Asthma & Immunology Clinic, P.A" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Allergy, Asthma & Immunology Clinic, P.A". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Allergy, Asthma & Immunology Clinic, P.A, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy, Asthma & Immunology Clinic, P.A, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".